Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
821
datasets available to search
ShareScore release 0.9.0
Dataset results
821 results for “anticoagulant”
Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
ClinicalTrials.gov study NCT04660747. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Reversal of the Antithrombotic Action of New Oral Anticoagulants
ClinicalTrials.gov study NCT01478282. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oral Surgery in Patients Taking Direct Oral Anticoagulants
ClinicalTrials.gov study NCT04505475. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
ClinicalTrials.gov study NCT00932100. IPD Sharing: Not stated. Countries: 4. Publications: 4.
Direct oral anticoagulants in treatment of cerebral venous thrombosis: systematic review
Open the record for dataset details and reuse information.
High rates of anticoagulant rodenticide exposure in California Barred Owls
Open the record for dataset details and reuse information.
Data from: Genome-wide expression reveals multiple systemic effects associated with detection of anticoagulant poisons in bobcats (Lynx rufus)
Open the record for dataset details and reuse information.
Direct oral anticoagulants in atrial fibrillation patients with concomitant hyperthyroidism
Open the record for dataset details and reuse information.
Data from: Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence
Objective: To examine the relative impact of three management options in patients less than 60 years old with cryptogenic stroke and a patent foramen ovale (PFO): PFO closure plus antiplatelet therapy, antiplatelet therapy alone, and anticoagulation alone. Design: Systematic review and network meta-analysis (NMA) supported by complementary external evidence Data sources: Medline, EMBASE, and Cochrane CENTRAL. Study selection: Randomised controlled trials (RCTs) addressing PFO closure and/or medical therapies in patients with PFO and cryptogenic stroke. Review methods: We conducted an NMA complemented with external evidence and rated certainty of evidence using the GRADE system. Results: Ten RCTs in eight studies proved eligible (n=4416). PFO closure versus antiplatelet therapy probably results in substantial reduction in ischaemic stroke recurrence (risk difference per 1000 patients over 5 years [RD]: -87, 95% credible interval [CrI] -100 to -33; moderate certainty). Compared with anticoagulation, PFO closure may confer little or no difference in ischaemic stroke recurrence (low certainty) but probably has a lower risk of major bleeding (RD -20, 95% Crl -27 to -2, moderate certainty). Relative to either medical therapy, PFO closure probably increases the risk of persistent atrial fibrillation (RD 18, CI +5 to +56, moderate certainty) and device-related adverse events (RD +36, 95% CI +23 to +50, high certainty). Anticoagulation, compared to antiplatelet therapy, may reduce the risk of ischaemic stroke recurrence (RD -71, 95% CrI -100 to +17, low certainty), but probably increases the risk of major bleeding (RD +12, CrI -5 to +65, moderate certainty). Conclusions: In patients less than 60 years old, PFO closure probably confers an important reduction in ischaemic stroke recurrence compared to antiplatelet therapy alone but may make no difference compared to anticoagulation. PFO closure incurs a risk of persistent atrial fibrillation and device-related adverse events. Compared to alternatives, anticoagulation probably increases major bleeding.
Anticoagulant and anti-inflammatory effects of fondaparinux sodium in anterior cruciate ligament reconstruction in patients at high risk of VTE: A Randomized Controlled Trial
Open the record for dataset details and reuse information.
Anticoagulation in AF patients
<p>This evaluated Iraqi PCPs' KAP toward anticoagulation administration in AF patients </p>
Once Weekly Subcutaneous Ports for the Administration of Anticoagulants
ClinicalTrials.gov study NCT00774748. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Renal Function Availability to Community Pharmacist for Dispensing Direct Oral Anticoagulant in Ambulatory Patients on Bleeding Occurrence
ClinicalTrials.gov study NCT06739603. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation
ClinicalTrials.gov study NCT07208695. IPD Sharing: NO. Countries: 0. Publications: 3.
Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea
ClinicalTrials.gov study NCT05022563. IPD Sharing: NO. Countries: 1. Publications: 0.
Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis
ClinicalTrials.gov study NCT06209892. IPD Sharing: NO. Countries: 0. Publications: 3.
Anticoagulant Utilization Pattern
ClinicalTrials.gov study NCT01847560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA
ClinicalTrials.gov study NCT02657616. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
ClinicalTrials.gov study NCT02526303. IPD Sharing: Not stated. Countries: 0. Publications: 2.
SNAP AF-52: Dose Appropriateness and Adherence to Oral Anticoagulation in Adults ≥65 With Atrial Fibrillation in Primary Care (Ordu, Türkiye)
ClinicalTrials.gov study NCT07242326. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.